L
Liminatus Pharma, Inc. (LIMN)
NCM – Real vaqt narxi. Valyuta: USD
0.11
-0.00 (-2.69%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
0.11
+0.00 (2.95%)
Bozordan keyin: Aug 12, 2026, 4:27 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.11
-0.00 (-2.69%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
0.11
+0.00 (2.95%)
Bozordan keyin: Aug 12, 2026, 4:27 PM EDT
Liminatus Pharma, Inc., preclinical bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda saratonni davolash usullarini ishlab chiqish bilan shug'ullanadi. U ilg'or qattiq o'smalar, shu jumladan mayda hujayrali o'pka saratonini davolash uchun I bosqich klinik sinovida bo'lgan insonlashtirilgan anti CD47 monoklonal antitelasi bo'lgan IBA101ni ishlab chiqadi. Kompaniya 2018 yilda tashkil etilgan va Kaliforniyaning Serritos shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Beom Kyu Choi | Chief Technology Officer & Member of Scientific Advisory Board |
| Dr. Byong Chul Yoo Ph.D. | Chief Science Officer & Member of Scientific Advisory Board |
| Mr. Chris Kim J.D., L.L.M. | CEO, Chairman & President |
| Mr. Scott Dam | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-04 | 8-K | tm2622207d1_8k.htm |
| 2026-07-30 | 8-K | tm2621658d1_8k.htm |
| 2026-07-24 | 8-K | tm2621298d1_8k.htm |
| 2026-07-13 | DEF 14A | tm264954-2_def14.htm |
| 2026-07-06 | 8-K | tm2619730d1_8k.htm |
| 2026-06-30 | PRE 14A | tm264954-1_pre14a.htm |
| 2026-06-24 | S-1 | limn-20260331xs1.htm |
| 2026-06-18 | D | |
| 2026-06-03 | 8-K | tm2616851d1_8k.htm |
| 2026-05-27 | 8-K | tm2615785d1_8k.htm |